Shu Chen is a Principal Scientific Researcher in DMPK at Genentech Inc., specializing in pharmacokinetics and drug transporter interactions. With over 10 years of experience in pharmaceutical formulation and manufacturing processes, Shu has expertise in PBPK modeling and statistical tools for process optimization. Shu's previous roles include working as a Scientific Leader at Apotex Inc. and as a Researcher at the University of Toronto, where they conducted significant research in drug delivery systems for cancer treatments. Shu holds both a Bachelor of Science and a Master of Science in Pharmaceutical Sciences from the University of Toronto.
This person is not in the org chart
This person is not in any teams
This person is not in any offices